Clot-Code® Thrombophilia Gene Panel: In progress with SFDA....

Precision genetics for confident thrombophilia risk assessment

Clot-Code® Thrombophilia Gene Panel is a reliable simplex molecular diagnostic solution designed to support accurate detection of key genetic variants associated with inherited thrombophilia. Each clinically relevant mutation—MTHFR I, MTHFR II, Factor V Leiden (FVL), Factor II (FII), and PAI—is detected individually.

Developed for high-performance laboratory environments, Clot-Code® combines robust assay design with consistent reproducibility, enabling laboratories to deliver dependable, mutation-specific results with confidence. The kit is optimized for routine molecular diagnostics and supports efficient decision-making in both clinical and research settings.

Key advantages

• Simplex assay design

• Comprehensive coverage of major thrombophilia-related genes

• High analytical accuracy and reproducibility

• Optimized for molecular diagnostic laboratories

• CE-IVD compliant for in vitro diagnostic use

• Developed and produced in Saudi Arabia

Clot-Code® empowers laboratories with a trusted genetic testing solution that aligns innovation, quality, and clinical relevance—supporting better outcomes through precision diagnostics.

Published Research Article related to our Product:

https://www.sciencedirect.com/science/article/abs/pii/S1246782025000473

https://www.medrxiv.org/content/10.1101/2023.10.25.23297518v1.full-text

https://pubs.rsc.org/en/content/articlelanding/2025/ay/d5ay00215j/unauth